CRISPR Therapeutics AG (CRSP) Net Margin Growth (3y) (2019 - 2026)
CRISPR Therapeutics AG (CRSP) Net Margin Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,283.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 506.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -569.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 6,537.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | CRISPR Therapeutics AG | 4.57 Bn | 2.12 Bn | - | -837,842.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -837,842.00 |
| Dec 31, 2025 | 182.41 Mn |
| Sep 30, 2025 | 17.37 Mn |
| Jun 30, 2025 | 9.42 Mn |
| Mar 31, 2025 | 334,460.00 |
| Dec 31, 2024 | 212,214.00 |
| Sep 30, 2024 | 115,450.00 |
| Jun 30, 2024 | -2.45 Mn |
| Mar 31, 2024 | -213,814.00 |
| Dec 31, 2023 | 3.10 Mn |
| Jun 30, 2023 | 18.10 Mn |
| Mar 31, 2023 | 4.44 Mn |
| Dec 31, 2022 | -184.30 Mn |
| Sep 30, 2022 | -18.58 Mn |
| Jun 30, 2022 | -10.07 Mn |
| Mar 31, 2022 | -430,710.00 |
| Dec 31, 2021 | 4.03 Mn |
| Sep 30, 2021 | -642,330.00 |
| Jun 30, 2021 | 361,223.00 |
| Mar 31, 2021 | -1.89 Mn |